Anlotinib Not Yet Recruiting Phase 1 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03910270Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer